Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
07/2012
07/11/2012CN101679502B A new type of consensus interferon and preparation method thereof
07/11/2012CN101573448B Hla-a*1101-restricted wt1 peptide and pharmaceutical composition comprising the same
07/11/2012CN101282978B Macrocylic inhibitors of hepatitis c virus
07/11/2012CN101200730B IL-12 expression carrier as well as eukaryotic cell strain expressed thereby and uses thereof
07/11/2012CN101161283B New use of CMTM1-v17 and its antagon
07/11/2012CN101081870B Antineoplastic biological medicament PTD4-GFP-Apoptin fusion protein and preparation method thereof
07/11/2012CN101006097B Vla-4 antagonists
07/10/2012US8217157 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
07/10/2012US8217146 Neurotrophic factors and methods of use thereof
07/10/2012US8217142 Liquid phase peptide synthesis of KL-4 pulmonary surfactant
07/10/2012US8217141 Crystalline and amorphous forms of peptide
07/10/2012US8217139 Treatment for obesity
07/10/2012US8217138 Anti-inflammatory compounds and uses thereof
07/10/2012US8217084 Medicinal products incorporating bound organosulfur groups
07/10/2012US8217048 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
07/10/2012US8217017 Modulation of insulin like growth factor I receptor expression
07/10/2012US8217016 Application of mRNA for use as a therapeutic agent for tumorous diseases
07/10/2012US8217012 Peptides for targeting apoptotic cells and uses thereof
07/10/2012US8217011 Peptides, compositions and uses thereof
07/10/2012US8217010 Methods, compositions and articles of manufacture for contributing to the treatment of solid tumors
07/10/2012US8217009 Allorestricted peptide-specific T cells
07/10/2012US8217008 Methods of treating inflammatory disease using a soluble IL-20 receptor
07/10/2012US8217007 Synthetic peptide amides
07/10/2012US8217006 Inhibiting GS-FDH to modulate no bioactivity
07/10/2012US8217005 Controlled release of phenolic opioids
07/10/2012US8217002 Pheromones and the luteinizing hormone for inducing proliferation of neural stem cells and neurogenesis
07/10/2012US8217001 Modification of feeding behavior
07/10/2012US8217000 Method for elevating prolactin in mammals
07/10/2012US8216999 HCV NS3 protease inhibitors
07/10/2012US8216998 Treatment of ischemic events
07/10/2012US8216997 Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
07/10/2012US8216996 Multimer of extracellular domain of cell surface functional molecule
07/10/2012US8216995 Relieving pain associated with muscle contractions; treating conditions such as cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretions
07/10/2012US8216843 Artificially synthesized peptide
07/10/2012US8216834 Chimpanzee adenovirus vaccine carriers
07/10/2012US8216805 Knobs and holes heteromeric polypeptides
07/10/2012US8216795 Tuberculosis diagnostic test
07/10/2012US8216792 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene
07/10/2012US8216599 Administering hydroxytyrosol and oleuropein in a ratio of 1:1-200:1
07/10/2012US8216593 A protozoan FusM mating protein antigen and a carrier and adjuvants; triggering a T-cell, an humoral, or a mucosal cytotoxic immune response; passively blocking the mating at the gamete in vivo; genetic engineering; antiparasiticides; antiprotozoa agents; malaria; veterinary medicine; malaria; mammals
07/10/2012US8216592 Infection model for developing chemotherapeutic agents
07/10/2012US8216591 With collagen and a polysaccharide such as hydroxyethyl starch as stabilizer; reduced toxicity and/or a reduced immunogenicity
07/10/2012US8216584 Imaging, diagnosis and treatment of disease
07/10/2012US8216580 Sulfatases and methods of use thereof
07/10/2012US8216576 Method for inhibiting binding to B-cell receptor
07/10/2012US8216575 Inhibition of neovascularization with a soluble chimeric protein comprising VEGF FLT-1 and KDR domains
07/10/2012US8216569 Vascular endothelial growth factor 2
07/10/2012US8216568 Combination therapy with IgA1 proteases
07/10/2012US8216564 Herpes simplex virus (HSV) derived amplicon defective viral genome carrying at least one toxic foreign gene and an HSV-derived mutant helper virus; antitumor and anticarcinogenic agents
07/10/2012US8216562 Inhibiting non-hematopoietic cancer with interleukin 6
07/10/2012US8216549 Method for making a ligand-quantum dot conjugate
07/10/2012US8216172 Method of performing hemofiltration
07/10/2012CA2602249C Peptide and protein formulations with improved stability
07/10/2012CA2575694C Methods for purifying a trna synthetase fragment
07/10/2012CA2567797C Peptidic vasopressin receptor agonists
07/10/2012CA2544156C Non-pancreatic proteases for controlling plasma cholecystokinin (cck) concentration and for treating pain
07/10/2012CA2510893C Binding agents which inhibit myostatin
07/10/2012CA2484774C Intracranial treatment of neuropsychiatric disorders by clostridial neurotoxins such as botolinum toxin
07/10/2012CA2481369C Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease
07/10/2012CA2462930C Remodeling and glycoconjugation of peptides
07/10/2012CA2444821C Combination therapy using anti-angiogenic agents and tnfa
07/10/2012CA2443112C Granule with reduced dust potential
07/10/2012CA2439101C New medical uses of intercellular communication facilitating compounds
07/10/2012CA2437940C Methods of treating diabetes mellitus
07/10/2012CA2435712C Universal carrier for targeting molecules to gb3 receptor expressing cells
07/10/2012CA2417960C Method of using diketopiperazines and composition containing them
07/10/2012CA2417884C Plant derived antioxidants
07/10/2012CA2412783C Vaccine against cancerous diseases associated with the her-2/neu oncogene
07/10/2012CA2402017C Compositions and methods for the early diagnosis of ovarian cancer
07/10/2012CA2372583C Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines
07/10/2012CA2368677C Intramyocardial injection of autologous bone marrow
07/10/2012CA2340790C Human il-1 epsilon dna and polypeptides
07/10/2012CA2326499C Methods of selecting internalizing antibodies
07/10/2012CA2319327C Sterile complex of therapeutic peptide bond to a polysaccharide
07/10/2012CA2305816C Peptides capable of inhibiting the interaction between presenilins and the .beta.-amyloid peptide or its precursor
07/10/2012CA2291928C Produits anti-cancereux pour le traitement de la mucoviscidose
07/10/2012CA2246501C Stabilised growth hormone formulation and method of preparation thereof
07/10/2012CA2211324C Recombinant human alpha-fetoprotein and uses thereof
07/10/2012CA2194172C Neurturin and related growth factors
07/05/2012WO2012092526A1 Methods and systems for treatment of migraines and other indications
07/05/2012WO2012092510A2 Ocular drug delivery system
07/05/2012WO2012092367A1 Nucleic acid binding compounds, methods of making, and use thereof
07/05/2012WO2012092341A1 Methods of modifying insulin signaling using biliverdin reductase (bvr) and bvr derived peptides
07/05/2012WO2012092302A1 Cmet protein srm/mrm assay
07/05/2012WO2012092299A1 Therapeutic and diagnostic methods involving biglycan and utrophin
07/05/2012WO2012092266A1 Serpinin and variants thereof for increasing heart contractility and treating cardiovascular diseases
07/05/2012WO2012092114A2 Oxidosqualene cyclase as a protein target for anticancer therapeutics
07/05/2012WO2012091946A2 Method for inhibiting pathogens using a nutritional composition
07/05/2012WO2012091945A1 Use of nutritional compositions including lactoferrin in supporting resistance to diseases and conditions
07/05/2012WO2012091921A1 Use of nutritional compositions including lactoferrin in stimulating immune cells
07/05/2012WO2012091756A1 Non-natural mic proteins
07/05/2012WO2012091743A1 Oleanoyl peptide composition and a method of treating skin aging
07/05/2012WO2012091718A1 Polymalic acid-based nanobiopolymer compositions and methods for treating cancer
07/05/2012WO2012091590A1 A recombinant cytotoxin as well as a method of producing it
07/05/2012WO2012091534A1 Antibacterial agent for treating infectious diseases of bacterial origin
07/05/2012WO2012091449A2 Pharmaceutical composition comprising phosphorylated grasp for treating cystic fibrosis
07/05/2012WO2012091278A2 Nanoemulsion-type ophthalmic composition
07/05/2012WO2012091220A1 Composition for the prevention or treatment of neoplastic diseases, comprising mirna as an active ingredient
07/05/2012WO2012091137A1 GENE THERAPEUTIC AGENT USING TNF-α, CD40L, AND GM-CSF IN COMBINATION
07/05/2012WO2012091118A1 Therapeutic agent for ectopic pregnancy
1 ... 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 ... 3163